Synapse - Immunology Program Faculty

Results (321)

High progression-free survival after intermediate intensity double unit cord blood transplantation in adults

Journal Article

Barker, J. N.; Devlin, S. M.; Naputo, K. A.; Skinner, K.; Maloy, M. A.; Flynn, L.; Anagnostou, T.; Avecilla, S. T.; Scaradavou, A.; Cho, C.; more...
Blood Advances (2020)

Fulltext@MSK | Save

Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplant

Journal Article

Fabrizio, V. A.; Kernan, N. A.; Boulad, F.; Cancio, M.; Allen, J.; Higman, M.; Margossian, S. P.; Mauguen, A.; Prockop, S.; Scaradavou, A.; more...
Bone Marrow Transplantation (2020)

Fulltext@MSK | Save

The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD

Journal Article

Markey, K. A.; Schluter, J.; Gomes, A. L. C.; Littmann, E. R.; Pickard, A. J.; Taylor, B. P.; Giardina, P. A.; Weber, D.; Dai, A.; Docampo, M. D.; more...
Blood (2020)

Fulltext@MSK | Save

Baseline immune status predicts response to adoptive therapy with CMV cytotoxic T-Cells for refractory CMV

Meeting Abstract

Fabrizio, V.; Rodriguez-Sanchez, I.; Mauguen, A.; Dahi, P. B.; O'Reilly, R. J.; Prockop, S. E.
Biology of Blood and Marrow Transplantation (2020)

Fulltext@MSK | Save

Host T-cells contribute to immune reconstitution and improved outcome in recipients of CD34 selected T-cell depleted allografts (TCD HCT) with full hematopoietic cell but persistent mixed T-cell chimerism

Meeting Abstract

O'Reilly, R. J.; Koehne, G.; Heller, G.; Boulad, F.; Castro-Malaspina, H.; Giralt, S. A.; Jakubowski, A. A.; Kernan, N. A.; Papadopoulos, E. B.; Perales, M.; more...
Biology of Blood and Marrow Transplantation (2020)

Fulltext@MSK | Save

Population pharmacokinetic model demonstrates poor outcomes with ATG overexposure in adults undergoing ex vivo CD34-selected allogeneic hematopoietic cell

Meeting Abstract

Scordo, M.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Ruiz, J. D.; Bhatt, V.; Smith, M.; Shah, G. L.; O'Reilly, R. J.; Papadopoulos, E. B.; more...
Biology of Blood and Marrow Transplantation (2020)

Fulltext@MSK | Save

Rabbit anti-thymocyte globulin (ATG) exposure after ex vivo T-cell depleted hematopoietic cell transplantation is highly variable and impacts immune reconstitution in pediatric and young adult patients

Meeting Abstract

Lakkaraja, M.; Mauguen, A.; Boulad, F.; Spitzer, B.; Scaradavou, A.; Curran, K. J.; Cancio, M.; van Roessel, I.; Kernan, N. A.; O'Reilly, R. J.; more...
Biology of Blood and Marrow Transplantation (2020)

Fulltext@MSK | Save

The impact of individual co-morbidities in myeloablative ex vivo CD34+ selected allogeneic hematopoietic cell transplantation

Meeting Abstract

Shouval, R.; Fein, J. A.; Devlin, S. M.; Maloy, M. A.; Castillo Flores, N.; Lin, R. J.; Politikos, I.; Sanchez, M.; Scordo, M.; Shah, G. L.; more...
Biology of Blood and Marrow Transplantation (2020)

Fulltext@MSK | Save

Don't let the HCT-CI fool you: Similar outcomes with myeloablative CD34+ selected allo-HCT compared to unmodified RIC allo-HCT in patients with AML or MDS and high comorbidity scores

Meeting Abstract

Pennisi, M.; Cho, C.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Tomas, A. A.; Castillo, N.; Lin, R. J.; Politikos, I.; Sanchez-Escamilla, M.; more...
Biology of Blood and Marrow Transplantation (2020)

Fulltext@MSK | Save

Outcomes of two chemotherapy-based preparatory regimens compared to tbi-based conditioning when used with CD34(+) selected T-cell depleted alloHCT for high risk hematologic malignancies: Prospective clinical trial NCT 01119066

Meeting Abstract

O'Reilly, R. J.; Koehne, G.; Boulad, F.; Heller, G.; Klein, E.; Barker, J. N.; Castro-Malaspina, H.; Curran, K. J.; Hsu, K. C.; Jakubowski, A. A.; more...
Biology of Blood and Marrow Transplantation (2020)

Fulltext@MSK | Save